Publications in collaboration with researchers from Swiss Federal Institute of Technology in Zurich (2)

2016

  1. Independent candidate serum protein biomarkers of response to adalimumab and to infliximab in rheumatoid arthritis: An exploratory study

    PLoS ONE, Vol. 11, Núm. 4

2012

  1. Discovery of serum proteomic biomarkers for prediction of response to infliximab (a monoclonal anti-TNF antibody) treatment in rheumatoid arthritis: An exploratory analysis

    Journal of Proteomics, Vol. 77, pp. 372-382